Quarterly report pursuant to Section 13 or 15(d)

Fair Value Option

v3.24.3
Fair Value Option
9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Option Fair Value Option
The Corporation elects to account for certain financial instruments under the fair value option. For more information on the primary financial instruments for which the fair value option elections have been made, see Note 21 – Fair Value Option to the Consolidated Financial Statements of the Corporation’s 2023 Annual Report on Form 10-K. The following tables provide information about the fair value carrying amount and the
contractual principal outstanding of assets and liabilities accounted for under the fair value option at September 30, 2024 and December 31, 2023, and information about where changes in the fair value of assets and liabilities accounted for under the fair value option are included in the Consolidated Statement of Income for the three and nine months ended September 30, 2024 and 2023.
Fair Value Option Elections
September 30, 2024 December 31, 2023
(Dollars in millions)
Fair Value
 Carrying
 Amount
Contractual
 Principal
 Outstanding
Fair Value
Carrying
Amount Less
 Unpaid Principal
Fair Value
Carrying
Amount
Contractual
 Principal
 Outstanding
Fair Value
Carrying
  Amount Less
 Unpaid Principal
Federal funds sold and securities borrowed or purchased under agreements to resell
$ 176,229  $ 176,255  $ (26) $ 133,053  $ 133,001  $ 52 
Loans reported as trading account assets (1)
9,565  15,991  (6,426) 8,377  15,580  (7,203)
Trading inventory – other 13,731  n/a n/a 25,282  n/a n/a
Consumer and commercial loans 4,172  4,049  123  3,569  3,618  (49)
Loans held-for-sale (1)
3,141  3,784  (643) 2,059  2,873  (814)
Other assets 3,289  n/a n/a 1,986  n/a n/a
Long-term deposits 443  509  (66) 284  267  17 
Federal funds purchased and securities loaned or sold under agreements to repurchase
243,431  243,436  (5) 178,609  178,634  (25)
Short-term borrowings 6,478  6,501  (23) 4,690  4,694  (4)
Unfunded loan commitments 66  n/a n/a 67  n/a n/a
Accrued expenses and other liabilities 2,066  2,201  (135) 1,341  1,347  (6)
Long-term debt 53,554  55,209  (1,655) 42,809  46,707  (3,898)
(1)A significant portion of the loans reported as trading account assets and LHFS are distressed loans that were purchased at a deep discount to par, and the remainder are loans with a fair value near contractual principal outstanding.
n/a = not applicable
Gains (Losses) Related to Assets and Liabilities Accounted for Under the Fair Value Option
Three Months Ended September 30
2024 2023
(Dollars in millions)
Market making
 and similar
 activities
Other
Income
Total Market making
 and similar
 activities
Other
Income
Total
Federal funds sold and securities borrowed or purchased under agreements to resell $ 169  $ (2) $ 167  $ 45  $ (4) $ 41 
Loans reported as trading account assets 72  40  112  58  —  58 
Trading inventory – other (1)
539    539  (900) —  (900)
Consumer and commercial loans 30  7  37  (50) 15  (35)
Loans held-for-sale (2)
  23  23  —  (38) (38)
Short-term borrowings 231    231  (1) —  (1)
Unfunded loan commitments   7  7  (1)
Accrued expenses and other liabilities 13    13  197  —  197 
Long-term debt (3)
(877) (4) (881) 863  (4) 859 
Other (4)
(108) (9) (117) (7) (4)
Total $ 69  $ 62  $ 131  $ 204  $ (21) $ 183 
Nine Months Ended September 30
2024 2023
Federal funds sold and securities borrowed or purchased under agreements to resell $ 277  $ (6) $ 271  $ 27  $ (12) $ 15 
Loans reported as trading account assets 77  40  117  208  —  208 
Trading inventory – other (1)
1,320    1,320  2,065  —  2,065 
Consumer and commercial loans 86  26  112  (189) 56  (133)
Loans held-for-sale (2)
  6  6  —  (22) (22)
Short-term borrowings 304    304  10  —  10 
Unfunded loan commitments   (13) (13) (1) 27  26 
Accrued expenses and other liabilities 411    411  246  —  246 
Long-term debt (3)
(610) (24) (634) 361  (27) 334 
Other (4)
(192) (16) (208) 46  —  46 
Total $ 1,673  $ 13  $ 1,686  $ 2,773  $ 22  $ 2,795 
(1)    The gains (losses) in market making and similar activities are primarily offset by (losses) gains on trading liabilities that hedge these assets.
(2)    Includes the value of IRLCs on funded loans, including those sold during the period.
(3)    The net gains (losses) in market making and similar activities relate to the embedded derivatives in structured liabilities and are typically offset by (losses) gains on derivatives and securities that hedge these liabilities. For the cumulative impact of changes in the Corporation’s own credit spreads and the amount recognized in accumulated OCI, see Note 12 – Accumulated Other Comprehensive Income (Loss). For more information on how the Corporation’s own credit spread is determined, see Note 20 – Fair Value Measurements to the Consolidated Financial Statements of the Corporation’s 2023 Annual Report on Form 10-K.
(4)    Includes gains (losses) on other assets, long-term deposits and federal funds purchased and securities loaned or sold under agreements to repurchase.
Gains (Losses) Related to Borrower-specific Credit Risk for Assets and Liabilities Accounted for Under the Fair Value Option
Three Months Ended September 30 Nine Months Ended September 30
(Dollars in millions) 2024 2023 2024 2023
Loans reported as trading account assets $ 48  $ 19  $ (16) $ 55 
Consumer and commercial loans 7  23  41 
Loans held-for-sale 7  (17) 6  (17)
Unfunded loan commitments 7  (13) 27 
Long-term debt   —  (3) —